Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe A Lysy

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Endocrinology and Metabolism|January 26, 2023
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric studyLaure Boutsen, Elise Costenoble, Olivier Pollé, et al.
Journal of Diabetes Research|September 26, 2014
Characteristics and determinants of partial remission in children with type 1 diabetes using the insulin-dose-adjusted A1C definitionAurore Pecheur, Thierry Barrea, Valérie Vandooren, et al.
Journal of Diabetes Research|June 7, 2024
Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB StudyMaude Beckers, Olivier Polle, Paola Gallo, et al.
World Journal of Gastroenterology|June 21, 2008
Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectivesPhilippe-A Lysy, Mustapha Najimi, Xavier Stephenne, et al.
Journal of Diabetes Research|August 31, 2019
Early Treatment with Empagliflozin and GABA Improves <i>β</i>-Cell Mass and Glucose Tolerance in Streptozotocin-Treated MiceCaroline Daems, Sophie Welsch, Hasnae Boughaleb, et al.
Frontiers in Endocrinology|August 11, 2023
Case Report: Aggressive neural crest tumors in a child with familial von Hippel Lindau syndrome associated with a germline <i>VHL</i> mutation (c.414A>G) and a novel <i>KIF1B</i> gene mutationLucie Landen, Anne De Leener, Manon Le Roux, et al.
Pediatric Transplantation|November 27, 2008
Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantationIvone Malla, Philippe A Lysy, Nathalie Godefroid, et al.
Plos One|November 30, 2023
Post-Hypoglycemic hyperglycemia are highly relevant markers for stratification of glycemic variability and partial remission status of pediatric patients with new-onset type 1 diabetesAntoine A Harvengt, Olivier G Polle, Manon Martin, et al.
The Review of Diabetic Studies : RDS|June 28, 2013
Islet neogenesis: a possible pathway for beta-cell replenishmentSusan Bonner-Weir, Lili Guo, Wan-Chun Li, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 15, 2021
Characterization and risk factors of hyperglycaemia during treatment of childhood hematologic malignanciesSophie Welsch, Kiswendsida Sawadogo, Bénédicte Brichard, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Endocrinology and Metabolism|January 26, 2023
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric studyLaure Boutsen, Elise Costenoble, Olivier Pollé, et al.
Journal of Diabetes Research|September 26, 2014
Characteristics and determinants of partial remission in children with type 1 diabetes using the insulin-dose-adjusted A1C definitionAurore Pecheur, Thierry Barrea, Valérie Vandooren, et al.
Journal of Diabetes Research|June 7, 2024
Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB StudyMaude Beckers, Olivier Polle, Paola Gallo, et al.
World Journal of Gastroenterology|June 21, 2008
Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectivesPhilippe-A Lysy, Mustapha Najimi, Xavier Stephenne, et al.
Journal of Diabetes Research|August 31, 2019
Early Treatment with Empagliflozin and GABA Improves <i>β</i>-Cell Mass and Glucose Tolerance in Streptozotocin-Treated MiceCaroline Daems, Sophie Welsch, Hasnae Boughaleb, et al.
Frontiers in Endocrinology|August 11, 2023
Case Report: Aggressive neural crest tumors in a child with familial von Hippel Lindau syndrome associated with a germline <i>VHL</i> mutation (c.414A>G) and a novel <i>KIF1B</i> gene mutationLucie Landen, Anne De Leener, Manon Le Roux, et al.
Pediatric Transplantation|November 27, 2008
Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantationIvone Malla, Philippe A Lysy, Nathalie Godefroid, et al.
Plos One|November 30, 2023
Post-Hypoglycemic hyperglycemia are highly relevant markers for stratification of glycemic variability and partial remission status of pediatric patients with new-onset type 1 diabetesAntoine A Harvengt, Olivier G Polle, Manon Martin, et al.
The Review of Diabetic Studies : RDS|June 28, 2013
Islet neogenesis: a possible pathway for beta-cell replenishmentSusan Bonner-Weir, Lili Guo, Wan-Chun Li, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 15, 2021
Characterization and risk factors of hyperglycaemia during treatment of childhood hematologic malignanciesSophie Welsch, Kiswendsida Sawadogo, Bénédicte Brichard, et al.
Pageof 5